Improving Safety in Pediatric Thyroidectomy by PTH Measurements

Sponsor
Hospital de Niños R. Gutierrez de Buenos Aires (Other)
Overall Status
Completed
CT.gov ID
NCT04690842
Collaborator
(none)
66
70

Study Details

Study Description

Brief Summary

We implemented a previously reported algorithm based on intra-postoperative PTH measurements with selected cut-off values, both to predict post-thyroidectomy hypoparathyroid hypocalcemia, and to guide postsurgical management. The objective of the study was to assess if this strategy was useful to reduce hypocalcemia, post-surgery calcium sampling and hospitalization length.

Condition or Disease Intervention/Treatment Phase
  • Diagnostic Test: PTH measurements post-thyroidectomy (at 5 and 60 min post thyroid removal)

Detailed Description

Sixty-six patients were included in the analysis. Based on their intra-operatory PTH determinations, patients were classified according to their post-surgical hypoparathyroidism risk and were either immediately treated with calcium and vitamin D1-25 supplementation (high-risk) or assigned to clinical control and routine calcium sampling (low-risk). The outcomes and overall results of these therapeutical approaches were compared with those of a control group, started on treatment when TCa levels dropped below normal.

In the high-risk subgroup (n=30) five patients showed hypocalcemia within the first 24 hours. Compared with the high-risk control subgroup, the incidence of hypocalcemia fell from 100% to 17% (p<0.001), and the median hospitalization length from 6 to 3 days (p<0.001).

In the low-risk subgroup (n=36) 28 patients remained normocalcemic with significantly less calcium sampling (p<0.001). Eight patients had hypocalcemia; 7 of them required neck dissection, which was the only risk factor related to post-surgical hypoparathyroidism (RR: 2.1 [CI 95% 1.4-3.1], P<0.001).

Compared to the control group, overall incidence of hypocalcemia was reduced by 58 %.

This approach improved patient's safety by reducing the occurrence of hypocalcemia and the length of hospitalization after thyroidectomy in pediatric patients. Preventive calcium supplementation seems to be more beneficial in patients undergoing neck dissection.

Study Design

Study Type:
Observational
Actual Enrollment :
66 participants
Observational Model:
Cohort
Time Perspective:
Prospective
Official Title:
Implementation of PTH Measurement Intra / Post Thyroidectomy to Improve Post Surgical Safety in Pediatric Patients
Actual Study Start Date :
Jun 1, 2014
Actual Primary Completion Date :
Apr 1, 2020
Actual Study Completion Date :
Apr 1, 2020

Outcome Measures

Primary Outcome Measures

  1. Biochemical hypocalcemia post thyroidectomy occurrence [48 hours postthyroidectomy]

    total Calcium level < 8 mg/dl

  2. Symptomatic hypocalcemia post thyroidectomy ocurrence [48 hours posthyroidectomy]

    Signs o symptoms of hypocalcemia (Chvostek or Trousseau signs, tingling, numbness, muscle cramps, spasms, tetany or seizures

Secondary Outcome Measures

  1. days of hospitalization after thyroidectomy [up to 15 days after thyroidectomy]

    number of days that patient need hospitalization (high risk group)

  2. number of Calcium sampling [48 hours postthyroidectomy]

    number of venipuncture performed to control serum calcium level (low risk group)

Eligibility Criteria

Criteria

Ages Eligible for Study:
2 Years to 19 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Patients who underwent total thyroidectomy between January 2014 and April 2020
Exclusion Criteria:
  • Patients with known hyper or hypoparathyroidism, kidney failure, and those taking medications known to affect TCa, PTH, or vitamin D levels (octreotide, oral glucocorticoids, diuretics and antiepileptics), or any other condition that could interfere with calcium metabolism

Contacts and Locations

Locations

No locations specified.

Sponsors and Collaborators

  • Hospital de Niños R. Gutierrez de Buenos Aires

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

Responsible Party:
Analía Freire, Pediatric Endocrinology, PhD, Hospital de Niños R. Gutierrez de Buenos Aires
ClinicalTrials.gov Identifier:
NCT04690842
Other Study ID Numbers:
  • CEI 19.27
First Posted:
Dec 31, 2020
Last Update Posted:
Jan 6, 2021
Last Verified:
Jan 1, 2021
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Analía Freire, Pediatric Endocrinology, PhD, Hospital de Niños R. Gutierrez de Buenos Aires
Additional relevant MeSH terms:

Study Results

No Results Posted as of Jan 6, 2021